A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Vaccine Compared With AZD1222

Clinical trial NCT05426343 · COMPLETED

Trial details

NCT number: NCT05426343
Sponsor: Medigen Vaccine Biologics Corp.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Vaccine

Start date: 2022-07-09
Primary completion: 2022-10-10
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.